Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1996 1
1997 2
1998 3
1999 3
2000 4
2001 10
2002 7
2003 7
2004 12
2005 9
2006 14
2007 8
2008 14
2009 8
2010 10
2011 18
2012 21
2013 18
2014 16
2015 7
2016 6
2017 4
2018 5
2019 4
2020 2
2021 10
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.
Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB. Brown AJH, et al. Among authors: nathan pj. Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001. Cell. 2021. PMID: 34822784 Free article. Clinical Trial.
New approaches in psychiatric drug development.
van der Doef TF, Zaragoza Domingo S, Jacobs GE, Drevets WC, Marston HM, Nathan PJ, Tome MB, Tamminga CA, van Gerven JMA, Kas MJH. van der Doef TF, et al. Among authors: nathan pj. Eur Neuropsychopharmacol. 2018 Sep;28(9):983-993. doi: 10.1016/j.euroneuro.2018.06.006. Epub 2018 Jul 25. Eur Neuropsychopharmacol. 2018. PMID: 30056086 Review.
Assessment of cognitive safety in clinical drug development.
Roiser JP, Nathan PJ, Mander AP, Adusei G, Zavitz KH, Blackwell AD. Roiser JP, et al. Among authors: nathan pj. Drug Discov Today. 2016 Mar;21(3):445-53. doi: 10.1016/j.drudis.2015.11.003. Epub 2015 Nov 22. Drug Discov Today. 2016. PMID: 26610416 Free PMC article. Review.
Ginkgo and memory.
Nathan PJ, Harrison BJ, Bartholomeusz C. Nathan PJ, et al. JAMA. 2003 Feb 5;289(5):546; author reply 547-8. doi: 10.1001/jama.289.5.546-a. JAMA. 2003. PMID: 12578477 No abstract available.
The pharmacology of human working memory.
Ellis KA, Nathan PJ. Ellis KA, et al. Among authors: nathan pj. Int J Neuropsychopharmacol. 2001 Sep;4(3):299-313. doi: 10.1017/S1461145701002541. Int J Neuropsychopharmacol. 2001. PMID: 11602036 Free article. Review.
187 results